📰 Mark Diagnostics News
Page 2 - Mark Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Diagnostics. Real-time updates on events, politics, business and more.
July 25, 2023
Global Oncology Molecular Diagnostic Market report is generated by a team of multilingual researchers who are skilled at different languages and hence perform market research internationally. With this report, businesses can get clear idea about how the market is going to perform in the forecast years with understan...
June 5, 2023
BioMark Diagnostics Inc. , an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers, is pleased to announce that its latest leading-edge research was presented... | June 5, 2023
May 31, 2023
The new family of patent granted by USPTO strengthens BioMark's global intellectual property position in liquid biopsy and early cancer detection Vancouver, British Columbia--(Newsfile Corp. - May 31
May 3, 2023
New analyses from a large retrospective validation study of early lung cancer metabolomics panel, underscoring strength of BioMark's liquid biopsy platform, to be presented. Vancouver, British Columbia--(Newsfile
April 19, 2023
/PRNewswire/ -- The "COVID-19 Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering. Global COVID-19 Testing...
March 30, 2023
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "Differential Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,...
March 29, 2023
The latest report from Growth Plus Reports analyzes the production, applications, demand, major manufacturers, and SWOT analysis of the global digital
March 23, 2023
Major players in the clinical chemistry market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., ELITech Group, Beckman Coulter Inc., Thermo Fisher...
March 16, 2023
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an advanced stage liquid biopsy company with a focus on hard
March 1, 2023
Vancouver, British Columbia--(Newsfile Corp. - March 1, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an advanced stage liquid biopsy company with